C12Y 302/01051
Alpha-l-fucosidase
Official title: Alpha-L-fucosidase (3.2.1.51)
C12Y302/01051 (Alpha-l-fucosidase) appears on 29 US grants and 45 published applications in this corpus.
Search patents in C12Y- Granted patents
- 29
- Published applications
- 45
- Assignees
- 25
- Inventors
- 88
- Latest grant
- 9 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 2 |
| 2015 | 2 | 8 |
| 2016 | 1 | 3 |
| 2017 | 2 | 3 |
| 2018 | 5 | 4 |
| 2019 | 1 | 5 |
| 2020 | 2 | 2 |
| 2021 | 1 | 3 |
| 2022 | 3 | 1 |
| 2023 | 2 | 1 |
| 2024 | 1 | 3 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of enzyme that cleaves both alpha- and beta- 1,4-glycosidic bonds9 Sep 2025US 12,410,419 B2Korea University Research and Business Foundation
- Anti-CD20 glycoantibodies and uses thereof30 Jan 2024US 11,884,739 B2Academia Sinica
- Fusion protein for remodeling antibody glycoform26 Dec 2023US 11,851,691 B2Cho Pharma, Inc.
- Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells11 Jul 2023US 11,697,819 B2Yissum Research Development Company of the Hebrew University of Jerusalem
- Anti-TNF-alpha glycoantibodies and uses thereof17 May 2022US 11,332,523 B2Academia Sinica
- Fucosidase Enzymes For Therapeutic Applications1 Oct 2026US 2026/0297642 A1Universiteit Gent
- Feed additive compositions and methods for using the same23 Oct 2025US 2025/0325005 A1International N&H Denmark Aps
- Fucosidase mutants and the use thereof6 Feb 2025US 2025/0043325 A1Cho Pharma, Inc.
- Glycoside hydolases and their use in preventing and/or treating a pathogenic infection in an animal3 Oct 2024US 2024/0325507 A1International N&H Denmark Aps
- Using fucosidase to control afucosylation level of glycosylated proteins22 Aug 2024US 2024/0279704 A1Amgen Inc.
Most cited
By later US patents
- Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases39US 5,433,946 AHealth Research, Inc. · 1995
- Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain34US 6,756,523 B1Aventis Pharma S. A. · 2004
- Isolation and composition of novel glycosidases19US 6,300,113 B1New England Biolabs, Inc. · 2001
- Compositions and methods relating to universal glycoforms for enhanced antibody efficacy12US 10,023,892 B2Academia Sinica · 2018
- Methods for modifying human antibodies by glycan engineering12US 10,087,236 B2Academia Sinica · 2018